Clinical Study Comparing Panchatikta Pancha Prasrutika Basti and Lekhana Basti for Dyslipidemia

Comparative Clinical Trial To Evaluate The Efficacy Of Panchatikta Pancha Prasrutika Basti And Lekhana Basti In The Management Of Shonita Abhishyanda W.S.R.To Dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104662

Enrollment

Registered

2026-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between age group 20-60 years. 2.Patients having Deeptaagni. 3.Patients of either gender. 4.Patients fit for the procedure of Basti . 5.Patient Fulfilling the Diagnostic Criteria with or without the symptoms of Shonita Abhishyanda.

Exclusion criteria

Exclusion criteria: 1.Patients having other systemic illnesses. 2.Hyperlipidemia due to drugs e.g. Gluco corticoids etc. 3.Alcoholics and Drug abusers . 4.Patients which are contraindicated for the procedure of Basti .

Design outcomes

Primary

Measure	Time frame
1.There will be a Significant reduction in the Lipid levels after the administration of Panchatikta Pancha Prasrutika Basti. 2.There will be a Significant reduction in the Lipid levels after the administration of Lekhana Basti. 3.There will be no any Significant reduction in the Lipid levels after the administration of Panchatikta Pancha Prasrutika Basti 4.There will be no any Significant reduction in the Lipid levels after the administration of Lekhana Basti.Timepoint: Lipid Parameters will be assessed 1.before the treatment (1st Day) , 2.After the treatment (9th Day) 3.the day of followup (20th Day)	—

Measure

Time frame

1.There will be a Significant reduction in the Lipid levels after the administration of Panchatikta Pancha Prasrutika Basti. 2.There will be a Significant reduction in the Lipid levels after the administration of Lekhana Basti. 3.There will be no any Significant reduction in the Lipid levels after the administration of Panchatikta Pancha Prasrutika Basti 4.There will be no any Significant reduction in the Lipid levels after the administration of Lekhana Basti.Timepoint: Lipid Parameters will be assessed 1.before the treatment (1st Day) , 2.After the treatment (9th Day) 3.the day of followup (20th Day)

—

Secondary

Measure	Time frame
There will be significant changes in the symptoms associated with DyslipidemiaTimepoint: Symptoms associated with the Dyslipidemia will be assessed 1.before the treatment (1st Day) , 2.After the treatment (9th Day) 3.the day of followup (20th Day)	—

Countries

India

Contacts

Public ContactDr Dinesh B Patil

Parul Institute of Ayurved And Research, Vadodara

dr.dineshpatil3@gmail.com9039764509

Outcome results